Anavex Life Sciences Corp (NASDAQ:AVXL)

2.42
Delayed Data
As of 3:59pm ET
 +0.01 / +0.41%
Today’s Change
1.25
Today|||52-Week Range
4.09
+55.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization995.001.3K0.000.00
 
 
 
 
Operating ExpensesGross Income-995.00-1.3K0.000.00
 
 
 
General Expenses7.1M15.6M15.7M19.3M
 
 
 
 
 
Research And Development2.3M7.3M10.7M13.3M
 
 
 
 
 
Total Operating Expenses7.1M15.6M15.7M19.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.1M-15.6M-15.7M-19.3M
 
 
 
 
 
Extraordinary Credit84.8K212.6K75.2K0.00
 
 
 
 
Interest Expense On Debt5.2M0.000.000.00
 
 
Other Expenses70.6K-48.4K-47.6K-80.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.1M-14.7M-15.4M-19.0M
 
 
 
 
 
Income Taxes0.00-29.6K-2.0M-1.6M
 
 
 
 
Net Income-12.1M-14.7M-13.5M-17.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.6M35.2M40.8M44.7M
 
 
 
 
 
Shares To Calculate EPS Diluted18.6M35.2M40.8M44.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.60-$0.42-$0.33-$0.39
 
 
 
 
 
EPS Diluted-$0.65-$0.42-$0.33-$0.39